Coordinating risk assessments for radiation in outer space
In the next few decades, crewed missions to the moon and Mars will likely become frequent. One of the main challenges faced ...
JD Supra19h
Litigation Trends to Watch in 2025
Trends to Watch in 2025 As we welcome 2025, Wilson Sonsini litigators shed light on the emerging trends and key issues they ...
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s ...